Tissue TransplantationComplicityFetal Tissue TransplantationPersonhoodDirected Tissue DonationLifeBeginning of Human LifeBrain Tissue TransplantationTransplantation, AutologousAborted FetusTissue and Organ ProcurementHospitals, StateOrgan TransplantationLiver TransplantationHand TransplantationTransplantation, HomologousTransplantation, HeterotopicTransplantationTissue DonorsTransplantation ImmunologyBone Marrow TransplantationKidney TransplantationHematopoietic Stem Cell TransplantationGraft SurvivalPregnant WomenPrimary Ovarian InsufficiencyEthics, MedicalSkin TransplantationCryopreservationHeart TransplantationStem Cell TransplantationLung TransplantationTransplantation ConditioningBlood Transfusion, AutologousOvaryGraft RejectionCell TransplantationPancreas TransplantationIslets of Langerhans TransplantationTreatment OutcomeTransplantation ChimeraGraft vs Host DiseaseImmunosuppressive AgentsPeripheral Blood Stem Cell TransplantationTransplantation, IsogeneicLiving DonorsCord Blood Stem Cell TransplantationTime FactorsHeart-Lung TransplantationRetrospective StudiesCombined Modality TherapyRecurrenceImmunosuppressionTransplantation ToleranceHistocompatibility TestingWhole-Body IrradiationLiver FailurePostoperative ComplicationsMesenchymal Stem Cell TransplantationHematologic NeoplasmsFollow-Up StudiesMelphalanSurvival AnalysisTransplantation, HeterologousSurvival RateCyclophosphamideRemission InductionMultiple MyelomaWaiting ListsHistocompatibilityCorneal TransplantationBusulfanCyclosporineT-LymphocytesTacrolimusLymphoma, Non-HodgkinAntineoplastic Combined Chemotherapy ProtocolsBone Marrow PurgingCadaverHLA AntigensDisease-Free SurvivalHematopoietic Stem CellsHematopoietic Stem Cell MobilizationLeukemiaCarmustineMyeloablative AgonistsLiver DiseasesSalvage TherapyFacial TransplantationOrgan PreservationAntigens, CD34Donor SelectionTransplantsHodgkin DiseaseCells, CulturedPrognosisAcute DiseaseAntilymphocyte SerumEtoposideLymphocyte Culture Test, Mixed